• 1
    Barbier J-R, Neugebauer W, Morley P, Ross V, Soska M, Whitfield JF, Willick G 1997 Bioactivities and secondary structures of constrained analogues of human parathyroid hormone: Cyclic lactams of the receptor binding region. J Med Chem 40:13731380.
  • 2
    Mierke DF, Pellegrini M 1999 Parathyroid hormone and parathyroid hormome-related protein: Model systems for the development of osteoporosis therapy. Curr Pharm Design 5:2136.
  • 3
    Whitfield JF, Morley P, Willick G, Langille R, Ross V, MacLean S, Barbier J-R 1997 cyclization by a specific lactam increases the ability of human parathyroid hormone (hPTH)-(1-31)NH2 to stimulate bone growth in ovariectomized rats. J Bone Miner Res 12:12461252.
  • 4
    Neugebauer W, Barbier J-R, Sung WL, Whitfield JF, Willick GE 1995 Solution structure and adenylyl cyclase stimulating activities of C-terminal truncated human parathyroid hormone analogues. Biochemistry 34:88358842.
  • 5
    Miller B, Burns C, Travis J, Beale L, Sweeney, D, Schlegel B, Harden R, Jariwala N, Burke K, Labaudinière R, Uhl J 1997 Anabolic potency of PTH peptides correlates with cAMP stimulatory activity. J Bone Miner Res 12:S320.
  • 6
    Jouishomme H, Whitfield JF, Chakravarthy B, Durkin JP, Gagnon L, Isaacs RJ, MacLean S, Neugebauer W, Willick G, Rixon RH 1992 The protein kinase C activation domain of the parathyroid hormone. Endocrinology 130:5360.
  • 7
    Takasu T, Bringhurst FR 1999 Dual signaling and ligand selectivity of the human PTH/PTHrP receptor. J Bone Miner Res 14:1120.
  • 8
    Wronski TJ, Pun S, Liang H 1998 Age-related decrease and PTH-induced increase in vertebral mean wall thickness in female rats. Bone 23:S517.
  • 9
    Whitfield JF, Morley P, Ross V, Isaacs RJ, Rixon RH 1995 Restoration of severely depleted femoral trabecular bone in ovariectomized rats by parathyroid hormone-(1-34). Calcif Tissue Int 56:227231.
  • 10
    Whitfield JF, Morley P, Ross V, Preston E, Soska M, Barbier J-R, Isaacs RJ, MacLean S, Ohannessian-Barry L, Willick GE 1997 The hypotensive actions of osteogenic and nonosteogenic parathyroid hormone fragments. Calcif Tissue Int 60:302308.
  • 11
    Whitfield JF, Morley P, Willick GE, MacLean S, Ross V, Barbier J-R, Isaacs RJ 1999 Stimulation of femoral trabecular bone growth in ovariectomized rats by human parathyroid hormone (hPTH)-(1-30)NH2. Calcif Tissue Int 65:143147.
  • 12
    Whitfield JF, Morley P, Willick GE 1998 The Parathyroid Hormone: An Unexpected Bone Builder for Treating Osteoporosis. RG Les Company, Austin, TX, U.S.A.
  • 13
    Fraher LJ, Avram R, Watson PH, Hendy GN, Henderson JE, Chaong KL, Goltzman D, Morley P, Willick GE, Whitfield JF, Hodsman AB 1999 A comparison of the biochemical responses to parathyroid hormone (hPTH)-(1-31)NH2 and hPTH-(1-34) in healthy humans. J Clin Endocrinol Metab 84:27392743.
  • 14
    Mohan S, Kutilek S, Zhang C, Shen HG, Kodama Y, Srinivasan N, Baylink DJ 1998 Evidence that PTH effects on bone formation may involve modulation of PKC pathway in a mouse model. Bone 23:S449.